Comment

15.08.18

Stepping up the fight against AMR

Source: NHE July/August 2018

Professor Mark Baker, director of the Centre for Guidelines at NICE, explains what the organisation is doing to support the fight against antimicrobial resistance (AMR) and the challenges that lie ahead.

The global risk of AMR is clear. It is already estimated that around 50,000 deaths per year in the EU and US alone can be attributed to resistant strains of bacteria. Without effective action, this number will grow rapidly and harm millions of people in the future. Clinicians and the public are becoming increasingly aware that we need to use antibiotics appropriately, only taking them when they are likely to work and for people who we know will benefit. We are starting to see some progress with reduced antibiotic prescriptions.

Since the UK AMR Strategy was launched five years ago, significant headway has been made to tackle the threat of AMR. NICE published a guideline on antimicrobial stewardship in 2015 which aimed to change prescribing practice to help slow the emergence of AMR and ensure that antimicrobials remain an effective treatment for infection. 

According to a recent ESPAUR report, prescribing behaviours are gradually changing and the number of antibiotic prescriptions is decreasing. Despite this essential progress, resistance to antimicrobials is still growing and remains one of global healthcare’s biggest challenges. There is much work to be done to educate the public about the proper use of antibiotics and to ensure that prescribers follow professional guidance. 

At NICE, we are developing a suite of evidence-based antimicrobial prescribing guidelines for managing common infections aiming to optimise antimicrobial use and minimise the risk of AMR. In January, we published a guideline on sore throat (acute) antimicrobial prescribing. The evidence we reviewed found that most sore throats will get better without antibiotics. However, research suggests antibiotics are still prescribed in 60% of cases. Instead of prescribing them, NICE advises helping people manage their symptoms with pain relief, such as paracetamol or ibuprofen. 

We also have a series of topics in development to support the appropriate use of antibiotics for urinary tract infections (UTIs), due to be published in October. Although the majority of UTIs will require antibiotic treatment, we need to be smarter with our use of these medicines. Our draft lower UTI guideline advises healthcare professionals to ask patients about the severity and regularity of their symptoms before prescribing antibiotics. This includes asking about the steps they have taken to manage their illness, for example using painkillers, and may involve asking the patient for a urine sample, using the results to identify which antibiotic will work most effectively.

Antibiotics are often assumed to be a quick fix when feeling unwell, and too many patients are asking for them. This perception has to change. Our guidance on changing antimicrobial behaviours in the general population aims to achieve this. It includes recommendations for making people aware of self-care options to manage their symptoms – from resting and drinking fluids through to educating pre-school and schoolchildren on AMR and personal hygiene to reduce the spread of infection.

While effective stewardship of antibiotics is vital and necessary in the short term, in itself it is not a long-term solution. We need also to support the development of new antimicrobial medicines. This is why the Department of Health and Social Care is working with industry, NICE and NHS England to develop options for new funding models for innovative antimicrobials that support responsible use and offer incentives to companies to develop these essential new medicines. 

We now have a growing range of strategies and guidance in place to tackle AMR use head-on. With around 700,000 people dying each year around the world due to antimicrobial-resistant infections, the scale of this problem cannot be ignored. Empowering patients and healthcare professionals to preserve these vital medicines and use them prudently is one of our most effective, immediate defences in the fight against AMR – but it is absolutely critical we combine that with the development of new antimicrobials.

Comments

There are no comments. Why not be the first?

Add your comment

 

national health executive tv

more videos >

latest healthcare news

Pharmaceutical firms accused of illegally colluding to drive up drug prices, ‘costing the NHS millions’

24/05/2019Pharmaceutical firms accused of illegally colluding to drive up drug prices, ‘costing the NHS millions’

Four pharmaceutical firms have been accused of illegally colluding to restrict the supply of an anti-nausea tablet, drastically driving up prices... more >
Trust apologises for heart surgeon’s exclusion amidst a ‘toxic’ row inside a ‘feuding’ cardiac unit

24/05/2019Trust apologises for heart surgeon’s exclusion amidst a ‘toxic’ row inside a ‘feuding’ cardiac unit

The scandal-hit St George’s University Hospitals NHS FT has apologised for wrongly suspending a senior heart surgeon and admitted that a fr... more >
County council director and CCG CEO to lead STP in joint-role

24/05/2019County council director and CCG CEO to lead STP in joint-role

Hertfordshire and West Essex STP has announced a job-share partnership between the local county council and CCG to lead the STP. Iain MacBea... more >

681 149x260 NHE Subscribe button

the scalpel's daily blog

The introduction of state indemnity and the continued importance of MDO membership

22/05/2019The introduction of state indemnity and the continued importance of MDO membership

Dr Caroline Fryar, head of advisory services at the Medical Defence Union (MDU), explains why medical defence organisation (MDO) membership remains important following the introduction of state indemnity. On 1 April 2019, state indemnity for NHS contracted primary care work was introduced in England and Wales. Following this, the MDU surveyed 700 GPs and found that many do not know the full implications and limitations of state indemnit... more >
read more blog posts from 'the scalpel' >

interviews

How can winter pressures be dealt with? Introduce a National Social Care Service, RCP president suggests

24/10/2018How can winter pressures be dealt with? Introduce a National Social Care Service, RCP president suggests

A dedicated national social care service could be a potential solution to surging demand burdening acute health providers over the winter months,... more >
RCP president on new Liverpool college building: ‘This will be a hub for clinicians in the north’

24/10/2018RCP president on new Liverpool college building: ‘This will be a hub for clinicians in the north’

The president of the Royal College of Physicians (RCP) has told NHE that the college’s new headquarters based in Liverpool will become a hu... more >
Duncan Selbie: A step on the journey to population health

24/01/2018Duncan Selbie: A step on the journey to population health

The NHS plays a part in the country’s wellness – but it’s far from being all that matters. Duncan Selbie, chief executive of Pu... more >
Cutting through the fake news

22/11/2017Cutting through the fake news

In an era of so-called ‘fake news’ growing alongside a renewed focus on reducing stigma around mental health, Paul Farmer, chief exec... more >

last word

Hard to be optimistic

Hard to be optimistic

Rachel Power, chief executive of the Patients Association, warns that we must be realistic about the very real effects of continued underfunding across the health service. It’s now bey... more > more last word articles >

editor's comment

25/09/2017A hotbed of innovation

This edition of NHE comes hot on the heels of this year’s NHS Expo which, once again, proved to be a huge success at Manchester Central. A number of announcements were made during the event, with the health secretary naming the second wave of NHS digital pioneers, or ‘fast followers’, which follow the initial global digital e... read more >

health service focus